TMCnet News

CathWorks Ltd. Appoints James M. Corbett Chief Executive Officer
[October 27, 2017]

CathWorks Ltd. Appoints James M. Corbett Chief Executive Officer


KFAR SABA, Israel, Oct. 27, 2017 /PRNewswire/ -- CathWorks Ltd., a leader in the development of non-invasive Fractional Flow Reserve (FFR) measurements for guiding coronary interventions, announced today the appointment of James M. Corbett as its Chief Executive Officer. Corbett, an industry veteran with broad experience in global commercialization, has served as President, Boston Scientific International, CEO Home Diagnostics, CEO of ev3 Inc, CEO of Vertos Medical and CEO of Alphatec Spine.

Cath_Works_Logo

Guy Lavi, Founder of CathWorks, will continue in his role as President of CathWorks Ltd.  "We are excited to have Jim join to lead the company in its efforts to globally commercialize the FFRangio technology," said Lavi. CathWorks has made material advances of ate, including the closing of Series B financing of $15.8M during August as well as the recent announcement of the first enrollment of its FDA Clinical Trial, FAST-FFR (FFRangio Accuracy vs. STandard FFR).



"Having Jim join CathWorks at this point, demonstrates an important transition of CathWorks to the next stage of development. Jim brings the experience and achievement necessary to develop the global organization that can execute on the significant opportunity created by the FFRangio technology," said Scott Ward, Chairman of the Board of CathWorks.

The company believes that the FFRangio technology has the potential to become the standard of care in the cath lab, enhancing the diagnostic decision making of cardiologists around the world. "The CathWorks FFRangio  is truly a disruptive and breakthrough technology and I am excited to be working with the CathWorks team in Israel," said Corbett.


About CathWorks
CathWorks is a privately held Israeli company founded in 2013. The company develops digital healthcare products for the cardiovascular market and is focused on improving the utilization of coronary angiography data to ratify measurement-based medicine in the cath lab. CathWorks is backed by worldwide VCs as well as a strategic partner and has completed two series of financing.

For further information, please contact Ilanit Frank-Hakim, [email protected]

View original content:http://www.prnewswire.com/news-releases/cathworks-ltd-appoints-james-m-corbett-chief-executive-officer-300544794.html

SOURCE Cathworks Ltd.


[ Back To TMCnet.com's Homepage ]